Publication | Open Access
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
173
Citations
35
References
2013
Year
Our findings indicated that plasma miR-150 and miR-342 are novel important promising biomarkers in the diagnosis of AML. These novel and promising markers warrant validation in larger prospective studies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1